Tue, October 20, 2020
Mon, October 19, 2020
Fri, October 16, 2020
Thu, October 15, 2020
Wed, October 14, 2020
Tue, October 13, 2020
Mon, October 12, 2020

Geoff Meacham Maintained (BIIB) at Sell with Decreased Target to $235 on, Oct 15th, 2020


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-decreased-target-to-235-on-oct-15th-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Geoff Meacham of B of A Securities, Maintained "Biogen Inc." (BIIB) at Sell with Decreased Target from $255 to $235 on, Oct 15th, 2020.

Geoff has made no other calls on BIIB in the last 4 months.



There are 5 other peers that have a rating on BIIB. Out of the 5 peers that are also analyzing BIIB, 2 agree with Geoff's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Brian Abrahams of "RBC Capital" Maintained at Hold with Decreased Target to $277 on, Friday, September 18th, 2020
  • Carter Gould of "Barclays" Downgraded from Buy to Hold and Decreased Target to $280 on, Monday, June 22nd, 2020


These are the ratings of the 3 analyists that currently disagree with Geoff


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $355 on, Tuesday, October 13th, 2020
  • Marc Goodman of "SVB Leerink" Maintained at Buy with Decreased Target to $342 on, Wednesday, August 19th, 2020
  • Brian Skorney of "Baird" Maintained at Sell with Decreased Target to $228 on, Friday, June 19th, 2020

Publication Contributing Sources